Change - Announcement of Cessation::Retirement of Independent Non-Executive Director - Claudia Teo Kwee Yee

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
29-Sep-2021 17:51:28
Status
New
Announcement Sub Title
Retirement of Independent Non-Executive Director - Claudia Teo Kwee Yee
Announcement Reference
SG210929OTHR6484
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Retirement of Claudia Teo Kwee Yee as Independent Non-Executive Director of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr Lance Tan, Senior Vice President at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.

Additional Details

Name Of Person
Claudia Teo Kwee Yee
Age
55
Is effective date of cessation known?
Yes
If yes, please provide the date
15/10/2021
Detailed Reason (s) for cessation
In accordance with Regulation 85 of the Company's Constitution, Ms Claudia Teo Kwee Yee is one of the Directors to retire by rotation at the Company's forthcoming Annual General Meeting ("AGM"). However, she will not be offering herself for the re-election and will retain office until the conclusion of the AGM.

Based on its enquiries, the Company's sponsor, UOB Kay Hian Private Limited, is satisfied that, save as disclosed in the announcement, there are no material reasons for the retirement of Ms Claudia Teo Kwee Yee as the Independent Non-Executive Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
18/06/2015
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director; Chairperson of Nominating Committee and Risk Management Committee; a member of Audit Committee and Remuneration Committee.
Role and responsibilities
Duties of an Independent Director; Chairperson of Nominating Committee and Risk Management Committee; a member of Audit Committee and Remuneration Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Ms. Teo deemed to be interested in the 74,900 shares of the company held in the name of her spouse.
Past (for the last 5 years)
Nil
Present
1. A partner and head of the Corporate and Financial Services practice group of Harry Elias Partnership LLP
2. Ren Ci Hospital & Medicare Centre
3. The Hokkien Foundation (Hokkien Huay Kwan)